Search

everythinglearnresearchcommunity

for

Search:↓

FLRG and follistatin have different roles in wound healing.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Manage vitiligo with treatments, address emotions, and use camouflage techniques.

Dermoscopy is a useful tool for identifying features of skin conditions, but more research is needed to define its role in dermatology.

HIV can cause various severe or unusual skin conditions that help indicate the presence and stage of the disease.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

H19 boosts hair growth potential by activating Wnt signaling, possibly helping treat hair loss.

The document concludes that the technique allows for the detection of LDH activity in various tissues, showing where cells are actively metabolizing glucose.

A woman's hair turned white after taking a cancer drug called dasatinib.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Any medication can cause skin reactions, some due to allergies and others due to dosage or genetic factors.

Finasteride helps female-pattern hair loss.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Nanotechnology improves hair care products by enhancing ingredient stability, targeting treatment, and reducing side effects, but more research on its toxicity is needed.

Taking L-cystine and vitamin B6 can prevent hair loss caused by smoke in mice.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

Calcipotriol plus betamethasone with microneedling works better than tacrolimus for treating vitiligo.

Older women face various skin issues like dryness and thinning, and treatments are available but can have side effects; proper skin care and legal health decisions are important.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.